Ajulemic acid
Ajulemic acid (also known as CT3, IP-751, JBT-101, or anabasum) is a synthetic cannabinoid with anti-inflammatory and analgesic properties. It is a derivative of THC (tetrahydrocannabinol), which is the primary psychoactive compound found in cannabis. Unlike THC, ajulemic acid does not have significant psychoactive effects, making it a potential therapeutic agent for a variety of medical conditions.
Chemistry[edit | edit source]
Ajulemic acid is a synthetic analog of THC, specifically a derivative of the THC metabolite THC-COOH (11-nor-9-carboxy-THC). It is synthesized by condensing a suitable cyclohexenone with piperidine and then treating the resulting compound with sulfuric acid to yield ajulemic acid.
Pharmacology[edit | edit source]
Ajulemic acid acts as a selective agonist at the CB2 receptor, one of the two main cannabinoid receptors in the body. This receptor is primarily found on immune cells and is involved in regulating inflammation and immune response. By activating the CB2 receptor, ajulemic acid can reduce inflammation and pain without causing the psychoactive effects associated with activation of the CB1 receptor, which is the other main cannabinoid receptor and is primarily found in the brain.
Clinical uses[edit | edit source]
Ajulemic acid has been investigated for its potential use in a variety of medical conditions, including chronic pain, multiple sclerosis, arthritis, and cystic fibrosis. It has shown promise in preclinical and early clinical trials for these conditions, but further research is needed to fully establish its efficacy and safety.
Safety and side effects[edit | edit source]
In clinical trials, ajulemic acid has been generally well tolerated, with most side effects being mild and transient. The most common side effects include dry mouth, fatigue, and gastrointestinal symptoms. Unlike THC, ajulemic acid does not cause significant psychoactive effects, even at high doses.
Legal status[edit | edit source]
The legal status of ajulemic acid varies by country and is often tied to the legal status of cannabis and other cannabinoids. In some countries, it is classified as a controlled substance, while in others it is legal for medical use under certain conditions.
See also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
